Relaxin activates multiple cAMP signaling pathway profiles in different target cells.
Although RXFP1-cAMP signaling in HEK293T cell systems is now relatively well-defined, the signaling pathways activated by relaxin in its target cells and tissues are still unclear. This study aimed to examine the cAMP signaling of RXFP1 in cells that endogenously express the receptor. Seven cell types derived from various backgrounds were screened for receptor expression. Only in THP-1 cells and rat cardiac fibroblasts was there activation of the Galpha(i3)-Gbetagamma-phosphatidylinositol 3-kinase-protein kinase Czeta pathway, leading to cAMP accumulation. In all other cells there was activation of a combination of the initial pathways to affect cAMP. T-47D cells could activate only Galpha(s), whereas Colo 16 and rat renal fibroblasts from obstructed kidney could activate both Galpha(s) and Galpha(oB) pathways. Thus, the signaling pathways activated by relaxin are highly dependent upon the cell type under investigation, and this may help to explain the varied physiological responses exerted by relaxin in its different target tissues.
Department of Pharmacology, Monash University, Clayton, Victoria, Australia.
Michelle L
ML
Halls
Tim D
TD
Hewitson
Xiao-Lei
XL
Moore
Xiao-Jun
XJ
Du
Ross A D
RA
Bathgate
Roger J
RJ
Summers
D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism*; D019206:GTP-Binding Protein alpha Subunits, Gi-Go / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007329:Insulin Antagonists / Q000494:pharmacology; D037342:Pertussis Toxin / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051381:Rats; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism; D018000:Receptors, Peptide / Q000235:genetics / Q000378:metabolism; D012065:Relaxin / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects* / Q000235:genetics; D000077191:Wortmannin
D000730:Androstadienes; D000242:Cyclic AMP; D019206:GTP-Binding Protein alpha Subunits, Gi-Go; D007329:Insulin Antagonists; D037342:Pertussis Toxin; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D043562:Receptors, G-Protein-Coupled; D018000:Receptors, Peptide; D012065:Relaxin; D000077191:Wortmannin; C417543:RXFP1 protein, human